← FDA Drug Approvals (Drugs@FDA)

CANGRELOR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-08-11

Drug application

FDA Application #
ANDA213551
Application type
Abbreviated New Drug Application (Generic)
Brand name
CANGRELOR
Generic name
CANGRELOR
Active ingredients
CANGRELOR
Dosage form
POWDER
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
Gland Pharma Limited
First approval
2025-08-11

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown